Bioline RX Ltd Sponsored ADR (BLRX) has released an update.
BioLineRx Ltd., an Israel-based biopharmaceutical company, has been notified by Nasdaq of non-compliance with the minimum bid price requirement, as its American Depositary Shares traded below $1.00 for 30 consecutive days. The company has 180 days until November 11, 2024, to regain compliance, with the possibility of an extension. This notice does not affect BioLineRx’s operations or its listing on the Tel Aviv Stock Exchange.
For further insights into BLRX stock, check out TipRanks’ Stock Analysis page.
